Tweet from benryanwriter at November 30, 2022 at 12:47PM
The FDA has decided that the last remaining monoclonal antibody to treat Covid-19 is not effective against the dominant strains of SARS-CoV-2. Eli Lilly is withdrawing bebtelovimab from the market. Paxlovid, however, is still considered effective. https://t.co/c27kJcJ7CL
— Benjamin Ryan (@benryanwriter)
Nov 30, 2022
from http://twitter.com/benryanwriter